The Technical AnalystExchange: HKSE Sector: Healthcare Industry: Diagnostics & Research
Life Healthcare Group Price, Forecast, Insider, Ratings, Fundamentals & Signals
-6.49% HKD0.0720
America/New_York / 2 mai 2024 @ 22:47
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 133.23 mill |
| EPS: | -0.0200 |
| P/E: | -3.60 |
| Earnings Date: | Jun 28, 2024 |
| SharesOutstanding: | 1 850.42 mill |
| Avg Daily Volume: | 0.609 mill |
| RATING 2024-05-02 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | ||
| Gr.Profit | n/a | n/a | n/a | n/a | ||
| Ebit | n/a | n/a | n/a | n/a | ||
| Asset | n/a | n/a | n/a | n/a | ||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.60 | sector: PE 34.76 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.11x |
| Company: PE -3.60 | industry: PE 32.83 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
HKD 0.0720 - 0.0820 ( +/- 6.49%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | HKD0.0720 (-6.49% ) |
| Volume | 0.0280 mill |
| Avg. Vol. | 0.609 mill |
| % of Avg. Vol | 4.60 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 0928.HK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
0928.HK
Life Healthcare Group Limited, an investment holding company, provides genetic testing and health data analysis services in the People's Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. It offers a range of services and solutions for medical and health administration through its non-invasive tumor genetic testing technology. The company also engages in apparel retail; securities trading and investment; and money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Tack Fiori International Group Limited and changed its name to Life Healthcare Group Limited in June 2017. Life Healthcare Group Limited was incorporated in 2001 and is based in Wan Chai, Hong Kong.